Premium
Treatment of bloating and distension ‐ role of probiotics
Author(s) -
Agrawal A.,
Whorwell P.
Publication year - 2011
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2011.04766.x
Subject(s) - bloating , medicine , irritable bowel syndrome , abdominal distension , gastroenterology , probiotic , flatulence , abdominal pain , placebo , distension , constipation , calprotectin , randomized controlled trial , inflammatory bowel disease , pathology , disease , alternative medicine , biology , bacteria , genetics
1. Asare F, Simrén M. Mindfulness-based stress reduction in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2011; 34: 578–9. 2. Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M. How many functional somatic syndromes? J Psychosom Res 2001; 51: 549–57. 3. Mayer EA. The challenge of studying the biology of complex, symptom-based GI disorders. Gastroenterology 2008; 134: 1826–7. 4. Gaylord SA, Palsson OS, Garland EL, et al. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol 2011 [Epub ahead of print]. 5. Brandt LJ, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002; 97: S7–26.